05.01.2015 13:44:14

BioCryst Pharma Appoints Lynne Powell As Chief Commercial Officer - Quick Facts

(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) announced the appointment of Lynne Powell to the role of senior vice president and chief commercial officer, effective January 26, 2015. She brings 24 years of industry experience to BioCryst.

Most recently, Powell served as senior vice president of North American Commercial Operations at CSL Behring. Throughout her 17 year career at CSL Behring, she assumed increasing responsibilities within the R&D, and commercial functions of the organization.

Prior to CSL, she held positions of increasing responsibility within GlaxoWellcome's commercial strategy and clinical research organizations.

Analysen zu BioCryst Pharmaceuticalsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BioCryst Pharmaceuticals 8,60 -0,02% BioCryst Pharmaceuticals